ConvaTec, Beta Bionics partner to bring Unomedical's infusion set to iLet system
Beta Bionics and ConvaTec Group announced that ConvaTec's Unomedical subsidiary and Beta Bionics have entered into a collaboration and development agreement that will make portions of Unomedical's infusion sets available for use with the iLet Bionic Pancreas System. The arrangement between Beta Bionics and ConvaTec creates a deep and meaningful partnership between the two companies for the benefit of the diabetes community. The arrangement is non-exclusive, consistent with other Beta Bionics partnerships designed to protect patient choice. The Unomedical sets will be deployed in two pivotal trials testing the iLet in its insulin-only and bihormonal configurations in 2020. ConvaTec's Unomedical subsidiary develops, produces, and supplies a range of disposable infusion sets used in insulin infusion therapy, including their flexible-cannula sets currently used with insulin pumps.